NeuroTheryX Canada Ltd.

About us Company Mission NeuroTheryX is an R&D-driven company based in Toronto, dedicated to the discovery and commercialization of therapeutic drugs. The cornerstone of NeuroTheryX’s advantage is the novel and proven drug discovery platform. The company has also established a network of collaborations and interactions with academic and pharmaceutical sectors to help deliver viable clinical therapeutics. Technology Overview The number of FDA approved drugs has been static in recent years. The pharmaceutical industry is in great need of innovative approaches to overcome such difficulties. The company’s drug discovery approach rapidly determines mechanisms of action for drugs using a whole organism screening technology platform. This platform allows simultaneous screening and development of small molecules for disease indications. Once a drug has been identified, the platform allows the design and testing of new chemical entity (NCE) analogs. This approach builds significant value into drug discovery programs with the generation of powerful intellectual property portfolios. The NeuroTheryX platform is also successful in allowing the development of nutraceutical products from plant extracts. NeuroTheryX thus has the capability to transition therapeutics starting with natural extracts all the way to NCEs giving NeuroTheryX a full spectrum of therapeutic products in its pipeline.